Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial

Schizophr Res. 2010 Jan;116(1):16-9. doi: 10.1016/j.schres.2009.10.012.

Abstract

While weight-management interventions are effective in attenuating antipsychotic-induced weight, there is no available evidence on their long-term effectiveness. This study sought to investigate the 2-year effects of an early behavioural intervention (EBI) designed to prevent antipsychotic-induced weight gain in first-episode psychosis (FEP) patients. Sixty-one FEP patients were randomized to receive either EBI or treatment-as-usual. Intention-to-treat and observed-cases analysis showed that patients in the EBI group gained significantly less weight than those allocated to routine care at intervention completion (3-month follow-up) with treatment effects maintained over 3months. Differences between groups were no longer significant by 12months. Weight-management interventions may need to be offered for longer periods to maintain preventative effects. Alternatively, booster sessions may need to be regularly delivered after intervention completion.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use*
  • Cognitive Behavioral Therapy / methods*
  • Female
  • Humans
  • Longitudinal Studies
  • Male
  • Mental Disorders / drug therapy
  • Mental Disorders / rehabilitation*
  • Single-Blind Method
  • Weight Gain / physiology*
  • Young Adult

Substances

  • Antipsychotic Agents